Abstract
Skin cancer is the most common malignancy in the United States.1 While skin cancer is less common in people with skin of color, it is more often associated with an increased incidence of morbidity and mortality as compared to white counterparts.2,3 This imbalance has significant public health concerns. Current skin cancer campaigns focus on Caucasian patients in high-risk groups. There is a paucity of literature on skin cancer in skin of color. Most physicians do not immediately associate skin cancer with skin of color, and little is known about the sun-protective behaviors of those with skin of color. Similarly the collection of statistics for skin cancer in skin of color is challenging as non-melanoma skin cancers (NMSC) are not consistently reported to tumor registries, and many NMSCs in skin of color are reported as melanomas. According to the 2,000 census,4 by the year 2050, 50% of the US population will be non-white. This changing demographic, combined with the disparate mortality, makes it imperative that physicians become familiar with skin cancer in skin of color so that they may better educate these patients on risk factors and early detection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
US Department of Health and Human Services. Healthy People 2010. 2nd ed. Understanding and improving health and objectives for improving health. Vol 2. Washington, DC: US Government Printing Office; November 2000.
Gloster HM Jr, Brodland DG. The epidemiology of skin cancer. Dermatol Surg. 1996;22:217–226
Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2006. Ca Cancer J Clin. 2006;56:106–130.
US Census Bureau Population Division. Projections of the resident population by race, Hispanic origin, and nativity: middle series, 1999–2100. Washington, DC: US Census Bureau; 2000.
Montagna W. The architecture of black and white skin. J Am Acad Dermatol. 1991;24:29–37.
Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer. 1995;75:667–673.
Halder RM, Ara CJ. Skin cancer and photoaging in ethnic skin. Dermatol Clin. 2003;21:725–732
Halder RM, Ara CJ. Skin cancer and photoaging in ethnic skin. Dermatol Clin. 2003;21:725–732
American Cancer Society, Non melanoma skin cancer detailed guide. http://documents.cancer.org/118.00. Accessed 12/19/08.
Naruse K, Ueda M, Nagana T, et al. Prevalence of actinic keratoses in Japan. J Dermatol Sci. 1997;15:183–187.
Scotto J, Fears TR, Fraumeni JF. Incidence of nonmelanoma skin cancer in the United States. Washington, DC: US Government Printing Office; 1983. NIH report no. 83–2433
Weinstock MA. Epidemiology of melanoma. Cancer Treat Res. 1993;65:29–56.
Koh D, Wang H, Lee J, et al. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry Data 1968–1997. Br J Dermatol. 2003;148:1161–1166.
Halder RM, Bang KM. Skin cancer in blacks in the United States. Dermatol Clin. 1988;6:397–405.
Penello GA, Devesa S, Gail M. Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks. Cancer Epidemiol Biomarkers Prev. 2000;9:291–297.
Sing B, Bhaya M, Shaha A, et al. Presentation, course and outcome of head and neck cancer in African Americans: a case controlled study. Laryngoscope. 1998;108:1159–1163.
Chorun L, Norris JE, Gupta M. Basal Cell carcinoma in Blacks: a report of 15 cases. Am Plast Surg. 1994;33:90–95.
Nadiminti U, Rakkhit T, Washington C. Morpheaform basal cell carcinoma in African Americans. Dermatol Surg. 2004;30:1550–1552.
Lesher JL, d’Aubermont PC, Brown VM. Morpheaform basal cell carcinoma in a young black woman. J Dermatol Surg Oncol. 1988;14:200–203.
Cheng SY, Luk NM, Chong LY. Special features of non-melanoma skin cancer in Hong Kong Chinese patients: 10 year retrospective study. Hong Kong Med J. 2001;7:22–28.
Matsuoka LY, Schauer PK, Sordillo PP. Basal cell carcinoma in black patients. J Am Acad Dermatol. 1981;4(6):670–672.
Briley JJ, Chaveda K, Lynfield YL. Sunscreen use and usefulness in African Americans. J Drugs Dermatol. 2007;6(1):19–22.
Ferdinand KC, Armani AM. The management of hypertension in African Americans. Crit Pathw Cardiol J Evid Based Med. 2007 June;6(2):67–71.
Mora RG, Perniciaro C. Cancer of the skin in blacks: a review of 163 black patients with cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1981;5:535–543.
Hale EK, Jorizzo JL, Nehal KS, et al. Current concepts in the management of actinic keratosis. J Drugs Dermatol. 2004, March–April;3(2 Suppl):S3–16.
Suzuki T, Ueda M, Naruse K, et al. Incidence of actinic keratosis of Japanese in Kasai City, Hyogo. Dermatol Sci. 1997;16:74–78.
Halder RM, Bang KM. Skin cancer in blacks in the United States. Dermatol Clin. 1988;6:397–405.
Mora RG, Perniciaro C, Lee B. Cancer of the skin in blacks III: a review of nineteen black patients with Bowen’s disease. J Am Acad Dermatol. 1984;11:557–562.
Mora RG. Surgical and aesthetic considerations of cancer of the skin in the black American. Am J Dermatol Surg Oncol. 1986;12:24–31.
Fleming ID, Barnawell JR, Burlison PE, et al. Skin cancer in black patients. Cancer. 1975;35:600–605.
Schamroth JM, Weiss RM, Grieve TP. Verrucous Bowen’s disease in an African American patient. S Afr Med J. 1987;71:527–528.
Krishnan R, Lewis A, Orengo IG, et al. Pigmented Bowen’s disease (squamous cell carcinoma in situ): a mimic of malignant melanoma. Dermatol Surg. 2001;27:673–674.
Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer statistics review, 1975–2005, Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2005/. Accessed 12/18/08.
Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians and Blacks: an analysis of California Cancer Registry data, 1988–1993. Cancer Causes Control. 1997;8:246–252.
Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin. 2000;50(1):7–33.
Washington CV, Grimes PE. Incidence and prevention of skin cancer. Cosmetic Dermatol. 2003;16:46–48.
Stone ML, Styles AR, Cockerell CJ, et al. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis. 2001;67:133–138.
Akaraphanth R, Douglass MC, Lim HW. Hypopigmented mycosis fungoides: treatment and a 61/2 year follow up of 9 patients. J Am Acad Dermatol. 2000;42:33–39.
Wienstock MA, Horm JW. Mycosis fungoides in the United States. JAMA. 1988;260:42–46.
Stone MC, Styles AR, Cockerell CJ. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis. 2001;67:133–138.
Whitmore SE, Simmons-O’Brien E, Rotter FS. Hypopigmented mycosis fungoides. Arch Dermatol. 1994;130:476–480.
LeFlore IC. Misconceptions regarding elective plastic surgery in the black patient. J Natl Med Assoc. 1980;72:947–948.
Arnold HL, Franer FH. Keloids: etiology and management by excision and intensive prophylactic radiation. Arch Dermatol. 1959;80:772
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jackson, B.A. (2009). Skin Cancer in Skin of Color. In: MacFarlane, D.F. (eds) Skin Cancer Management. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88495-0_16
Download citation
DOI: https://doi.org/10.1007/978-0-387-88495-0_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-88494-3
Online ISBN: 978-0-387-88495-0
eBook Packages: MedicineMedicine (R0)